DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 151 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,272 | – | 100 | +9900.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q1 2022 | $119,000 | -48.0% | 12,830 | -45.2% | 0.00% | – |
| Q4 2021 | $229,000 | +151.6% | 23,424 | +770.1% | 0.00% | – |
| Q3 2021 | $91,000 | -14.2% | 2,692 | -7.4% | 0.00% | – |
| Q2 2021 | $106,000 | -27.9% | 2,907 | +12.5% | 0.00% | – |
| Q4 2020 | $147,000 | +37.4% | 2,584 | -0.9% | 0.00% | -100.0% |
| Q1 2020 | $107,000 | -85.6% | 2,607 | -78.2% | 0.00% | -80.0% |
| Q4 2019 | $743,000 | +143.6% | 11,937 | +32.8% | 0.01% | +150.0% |
| Q3 2019 | $305,000 | +771.4% | 8,990 | +898.9% | 0.00% | – |
| Q3 2018 | $35,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 4,104,140 | $93,041,000 | 43.52% |
| SV Health Investors, LLC | 1,716,303 | $38,909,000 | 20.55% |
| PURA VIDA INVESTMENTS, LLC | 68,154 | $1,545,000 | 0.65% |
| Redmile Group, LLC | 683,880 | $14,658,000 | 0.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 77,000 | $1,746,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 224,154 | $5,008,000 | 0.59% |
| EMERALD ADVISERS, LLC | 482,626 | $10,941,000 | 0.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 416,342 | $9,438,000 | 0.38% |
| Orbimed Advisors | 1,176,070 | $26,662,000 | 0.34% |
| VIKING GLOBAL INVESTORS LP | 2,394,625 | $54,286,000 | 0.33% |